日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Invertebrate iridescent virus 3 Putative hydrolase 080R (IIV3-080R) CSB-YP622165IAAL
CSB-EP622165IAAL
CSB-BP622165IAAL
CSB-MP622165IAAL
CSB-EP622165IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 063R (IIV3-063R) CSB-YP622166IAAL
CSB-EP622166IAAL
CSB-BP622166IAAL
CSB-MP622166IAAL
CSB-EP622166IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Asparagine--tRNA ligase, cytoplasmic (nrs-1), partial CSB-YP622167CXY
CSB-EP622167CXY
CSB-BP622167CXY
CSB-MP622167CXY
CSB-EP622167CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Intermediate filament protein ifd-2 (ifd-2) CSB-YP622168CXY
CSB-EP622168CXY
CSB-BP622168CXY
CSB-MP622168CXY
CSB-EP622168CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 054L (IIV3-054L) CSB-YP622169IAAL
CSB-EP622169IAAL
CSB-BP622169IAAL
CSB-MP622169IAAL
CSB-EP622169IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Putative serine/threonine-protein kinase 040L (IIV3-044L) CSB-YP622170IAAL
CSB-EP622170IAAL
CSB-BP622170IAAL
CSB-MP622170IAAL
CSB-EP622170IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 035R (IIV3-035R), partial CSB-YP622171IAAL
CSB-EP622171IAAL
CSB-BP622171IAAL
CSB-MP622171IAAL
CSB-EP622171IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Probable cysteine proteinase 024R (IIV3-024R), partial CSB-YP622172IAAL1
CSB-EP622172IAAL1
CSB-BP622172IAAL1
CSB-MP622172IAAL1
CSB-EP622172IAAL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Uncharacterized protein 015R (IIV3-015R) CSB-YP622173IAAL
CSB-EP622173IAAL
CSB-BP622173IAAL
CSB-MP622173IAAL
CSB-EP622173IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 3 Putative zinc finger protein 012R (IIV3-012R) CSB-YP622174IAAL
CSB-EP622174IAAL
CSB-BP622174IAAL
CSB-MP622174IAAL
CSB-EP622174IAAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable arginine--tRNA ligase, cytoplasmic (rrt-1), partial CSB-YP622175CXY
CSB-EP622175CXY
CSB-BP622175CXY
CSB-MP622175CXY
CSB-EP622175CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Uncharacterized protein F30B5.4 (F30B5.4) CSB-YP622176CXY
CSB-EP622176CXY
CSB-BP622176CXY
CSB-MP622176CXY
CSB-EP622176CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Importin subunit alpha-3 (ima-3), partial CSB-YP622177CXY
CSB-EP622177CXY
CSB-BP622177CXY
CSB-MP622177CXY
CSB-EP622177CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Zinc finger SWIM domain-containing protein 7 (ZSWIM7) CSB-YP622178HU
CSB-EP622178HU
CSB-BP622178HU
CSB-MP622178HU
CSB-EP622178HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Callithrix jacchus Tumor necrosis factor (TNF), partial CSB-YP622179CYL
CSB-EP622179CYL
CSB-BP622179CYL
CSB-MP622179CYL
CSB-EP622179CYL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig Zinc finger Ran-binding domain-containing protein 2 (ZRANB2) CSB-YP622180PI
CSB-EP622180PI
CSB-BP622180PI
CSB-MP622180PI
CSB-EP622180PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus Cytochrome b6-f complex subunit 6 (petL), partial CSB-YP622181CWP
CSB-EP622181CWP
CSB-BP622181CWP
CSB-MP622181CWP
CSB-EP622181CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus Photosystem II reaction center protein M (psbM), partial CSB-YP622182CWP
CSB-EP622182CWP
CSB-BP622182CWP
CSB-MP622182CWP
CSB-EP622182CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus Light-independent protochlorophyllide reductase subunit B (chlB), partial CSB-YP622183CWP
CSB-EP622183CWP
CSB-BP622183CWP
CSB-MP622183CWP
CSB-EP622183CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorokybus atmophyticus 30S ribosomal protein S4, chloroplastic (rps4) CSB-YP622184CWP
CSB-EP622184CWP
CSB-BP622184CWP
CSB-MP622184CWP
CSB-EP622184CWP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×